title: Therapeutic effect of an interval exercise training program in the management of erectile dysfunction in hypertensive patients.
abstract: The purpose of the present study was to determine the effect of an interval exercise training program on C-reactive protein and erectile dysfunction (ED) management in older male hypertensive patients. Twenty-two male hypertensive patients with ED (n=22; 62.10+/-5.23 years) were involved in interval exercise training (60%-79% heart rate max reserve) for 8 weeks for a duration of between 45 to 60 min/d, while an age-matched control hypertensive (n=21; 64.00+/-4.77 years) group remained sedentary during this period. The study revealed a significant effect of an exercise training program on erectile function of hypertensive patients with ED (P<.05). It was concluded that an exercise program is a possible effective noninvasive and nonpharmacologic management of ED in male hypertensive patients.
authors.affiliation: Physiotherapy/Physiology Department, Faculty of Medical Sciences, Jimma University, Ethiopia. siklam_86@yahoo.co.uk
authors.forename: Sikiru
authors.initials: S
authors.lastname: Lamina
authors.forename: Chuba G
authors.initials: CG
authors.lastname: Okoye
authors.forename: Theophilus T
authors.initials: TT
authors.lastname: Dagogo
mesh_terms: D000367:Age Factors; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002097:C-Reactive Protein / Q000378:metabolism*; D004311:Double-Blind Method; D007172:Erectile Dysfunction / Q000097:blood / Q000150:complications / Q000628:therapy*; D005081:Exercise Therapy / Q000379:methods*; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000150:complications / Q000628:therapy*; D018836:Inflammation Mediators / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011336:Probability; D012016:Reference Values; D018570:Risk Assessment; D012720:Severity of Illness Index; D018709:Statistics, Nonparametric; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D018836:Inflammation Mediators; D002097:C-Reactive Protein